Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1109

1.

Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.

Rosati G, Galli F, Cantore M, Bergamo F, Banzi M, Zampino MG, Mattioli R, Cardellino GG, Ronzoni M, Di Bartolomeo M, Tamberi S, Marchetti P, Rimassa L, Corsi D, Bochicchio AM, Artioli F, Labianca R, Galli F, Rulli E, Bilancia D, Bregni G; TOSCA (Three or Six Colon Adjuvant) Investigators.

Oncologist. 2020 Jan 13. doi: 10.1634/theoncologist.2019-0736. [Epub ahead of print]

2.

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.

Krasniqi E, Pizzuti L, Barchiesi G, Sergi D, Carpano S, Botti C, Kayal R, Sanguineti G, Marchetti P, Botticelli A, Marinelli D, Gamucci T, Natoli C, Grassadonia A, Tinari N, Tomao S, Tonini G, Santini D, Michelotti A, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Cazzaniga M, Moscetti L, Fabbri A, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Garufi C, Di Stefano P, Mirabelli R, Veltri E, Paris I, Giotta F, Lorusso V, Landucci E, Ficorella C, Roselli M, Adamo V, Ricciardi G, Russo A, Valerio MR, Berardi R, Pistelli M, Cannita K, Zamagni C, Garrone O, Baldini E, Livi L, Meattini I, Del Medico P, Generali D, De Maria R, Risi E, Ciliberto G, Villa A, Sperduti I, Mazzotta M, Barba M, Giordano A, Vici P.

J Cell Physiol. 2020 Jan 15. doi: 10.1002/jcp.29445. [Epub ahead of print]

PMID:
31943171
3.

[Appropriate use of trastuzumab in Lazio Region: therapeutic scenarios and estimation of possible savings for the Regional Health Service.]

Belleudi V, Rosa AC, Musicco F, Marchetti P, Martini N, Andriani A, Calamia T, Addis A.

Recenti Prog Med. 2019 Dec;110(12):604-614. doi: 10.1701/3278.32519. Italian.

PMID:
31909763
4.

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

Roberto M, Botticelli A, Cecere S, Cognetti F, Giusti R, Gelibter A, Nelli F, Nuti M, Santini D, Marchetti P.

Recenti Prog Med. 2019 Dec;110(12):587-593. doi: 10.1701/3278.32517. Italian.

PMID:
31909761
5.

'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view.

Ceccarelli F, Botticelli A, Gelibter AJ, Leccese I, Lucchetti R, Cortesi E, Valesini G, Marchetti P, Conti F.

Ann Rheum Dis. 2020 Jan 6. pii: annrheumdis-2019-216867. doi: 10.1136/annrheumdis-2019-216867. [Epub ahead of print] No abstract available.

PMID:
31907163
6.

Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells.

Demine S, Schiavo AA, Marín-Cañas S, Marchetti P, Cnop M, Eizirik DL.

Stem Cell Res Ther. 2020 Jan 3;11(1):7. doi: 10.1186/s13287-019-1523-3.

7.

Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program.

Baldini E, Lunghi A, Cortesi E, Turci D, Signorelli D, Stati V, Melotti B, Ricciuti B, Frassoldati A, Romano G, Ceresoli GL, Illiano A, Verderame F, Fasola G, Ricevuto E, Marchetti P, Pinto C, Cartenì G, Scotti V, Tibaldi C, Fioretto L, Giannarelli D.

Lung Cancer. 2020 Feb;140:59-64. doi: 10.1016/j.lungcan.2019.12.014. Epub 2019 Dec 20.

PMID:
31881412
8.

Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.

Igoillo-Esteve M, Oliveira AF, Cosentino C, Fantuzzi F, Demarez C, Toivonen S, Hu A, Chintawar S, Lopes M, Pachera N, Cai Y, Abdulkarim B, Rai M, Marselli L, Marchetti P, Tariq M, Jonas JC, Boscolo M, Pandolfo M, Eizirik DL, Cnop M.

JCI Insight. 2019 Dec 26. pii: 134221. doi: 10.1172/jci.insight.134221. [Epub ahead of print]

9.

A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.

Demine S, Garcia Ribeiro R, Thevenet J, Marselli L, Marchetti P, Pattou F, Kerr-Conte J, Devoogdt N, Eizirik DL.

Diabetologia. 2019 Dec 23. doi: 10.1007/s00125-019-05068-5. [Epub ahead of print]

PMID:
31873789
10.

CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer.

Cerbelli B, Botticelli A, Pisano A, Pernazza A, Campagna D, De Luca A, Ascierto PA, Pignataro MG, Pelullo M, Rocca CD, Marchetti P, Fortunato L, Costarelli L, d'Amati G.

Virchows Arch. 2019 Dec 18. doi: 10.1007/s00428-019-02722-6. [Epub ahead of print]

PMID:
31853625
11.

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.

Frassoldati A, Biganzoli L, Bordonaro R, Cinieri S, Conte P, Laurentis M, Mastro LD, Gori S, Lauria R, Marchetti P, Michelotti A, Montemurro F, Naso G, Pronzato P, Puglisi F, Tondini CA.

Future Oncol. 2019 Dec 18. doi: 10.2217/fon-2018-0942. [Epub ahead of print]

PMID:
31849236
12.

Influence of residential land cover on childhood allergic and respiratory symptoms and diseases: Evidence from 9 European cohorts.

Parmes E, Pesce G, Sabel CE, Baldacci S, Bono R, Brescianini S, D'Ippolito C, Hanke W, Horvat M, Liedes H, Maio S, Marchetti P, Marcon A, Medda E, Molinier M, Panunzi S, Pärkkä J, Polańska K, Prud'homme J, Ricci P, Snoj Tratnik J, Squillacioti G, Stazi MA, Maesano CN, Annesi-Maesano I.

Environ Res. 2019 Nov 22:108953. doi: 10.1016/j.envres.2019.108953. [Epub ahead of print]

13.

Stearoyl CoA desaturase is a gatekeeper that protects human beta cells against lipotoxicity and maintains their identity.

Oshima M, Pechberty S, Bellini L, Göpel SO, Campana M, Rouch C, Dairou J, Cosentino C, Fantuzzi F, Toivonen S, Marchetti P, Magnan C, Cnop M, Le Stunff H, Scharfmann R.

Diabetologia. 2020 Feb;63(2):395-409. doi: 10.1007/s00125-019-05046-x. Epub 2019 Dec 3.

14.

Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?

Sbardella E, Tenuta M, Sirgiovanni G, Gianfrilli D, Pozza C, Venneri MA, Cortesi E, Marchetti P, Lenzi A, Gelibter AJ, Isidori AM.

Clin Endocrinol (Oxf). 2019 Dec 1. doi: 10.1111/cen.14135. [Epub ahead of print]

PMID:
31788837
15.

Isometric Exercise Improves Redox Balance and Blood Pressure in Hypertensive Adults.

Olher RR, Rosa TS, Souza LHR, Oliveira JF, Soares BRA, Ribeiro TBA, Souza IRC, Neves RVP, Sousa CV, Deus LA, Marchetti PH, Simoes HG, Moraes MR.

Med Sci Sports Exerc. 2019 Nov 21. doi: 10.1249/MSS.0000000000002223. [Epub ahead of print]

PMID:
31764461
16.

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios.

Pizzuti L, Krasniqi E, Barchiesi G, Mazzotta M, Barba M, Amodio A, Massimiani G, Pelle F, Kayal R, Vizza E, Grassadonia A, Tomao S, Venuti A, Gamucci T, Marchetti P, Natoli C, Sanguineti G, Ciliberto G, Vici P.

J Cancer. 2019 Oct 12;10(24):5903-5914. doi: 10.7150/jca.35109. eCollection 2019. Review.

17.

Cervical Spine Motion During Vehicle Extrication of Healthy Volunteers.

Gabrieli A, Nardello F, Geronazzo M, Marchetti P, Liberto A, Arcozzi D, Polati E, Cesari P, Zamparo P.

Prehosp Emerg Care. 2019 Dec 20:1-9. doi: 10.1080/10903127.2019.1695298. [Epub ahead of print]

PMID:
31750763
18.

Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms.

Scoppola A, Strigari L, Barnabei A, Petasecca P, De Galitiis F, Fulgenzi CAM, Roselli M, De Lorenzo A, Di Renzo L, Marchetti P, Torino F.

Front Endocrinol (Lausanne). 2019 Nov 5;10:757. doi: 10.3389/fendo.2019.00757. eCollection 2019.

19.

Synthesis of N-acyl amide natural products using a versatile adenylating biocatalyst.

Marchetti PM, Richardson SM, Kariem NM, Campopiano DJ.

Medchemcomm. 2019 May 31;10(7):1192-1196. doi: 10.1039/c9md00063a. eCollection 2019 Jul 1.

20.

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.

Cortellini A, Vitale MG, De Galitiis F, Di Pietro FR, Berardi R, Torniai M, De Tursi M, Grassadonia A, Di Marino P, Santini D, Zeppola T, Anesi C, Gelibter A, Occhipinti MA, Botticelli A, Marchetti P, Rastelli F, Pergolesi F, Tudini M, Silva RR, Mallardo D, Vanella V, Ficorella C, Porzio G, Ascierto PA.

J Transl Med. 2019 Nov 15;17(1):376. doi: 10.1186/s12967-019-02132-x.

21.

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience.

Valeriani M, Marinelli L, Macrini S, Reverberi C, Aschelter AM, De Sanctis V, Marchetti P, Tronnolone L, Osti MF.

Radiat Oncol. 2019 Nov 14;14(1):205. doi: 10.1186/s13014-019-1414-x.

22.

Atopy Modifies the Association Between Inhaled Corticosteroid Use and Lung Function Decline in Patients with Asthma.

Marcon A, Marchetti P, Antó JM, Cazzoletti L, Cerveri I, Corsico A, Ferreira DS, Garcia-Aymerich J, Gislason D, Heinrich J, Jõgi R, Johannessen A, Leynaert B, Malinovschi A, Pin I, Probst-Hensch N, Weyler J, Janson C, Jarvis D, Accordini S; Ageing Lungs in European Cohorts (ALEC) study.

J Allergy Clin Immunol Pract. 2019 Nov 5. pii: S2213-2198(19)30914-6. doi: 10.1016/j.jaip.2019.10.023. [Epub ahead of print]

23.

Chronic bronchitis without airflow obstruction, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases.

Ferrari M, Piccinno E, Marcon A, Marchetti P, Cazzoletti L, Pirina P, Battaglia S, Grosso A, Squillacioti G, Antonicelli L, Verlato G, Pesce G.

PLoS One. 2019 Nov 7;14(11):e0224999. doi: 10.1371/journal.pone.0224999. eCollection 2019.

24.

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes.

Ramos-Rodríguez M, Raurell-Vila H, Colli ML, Alvelos MI, Subirana-Granés M, Juan-Mateu J, Norris R, Turatsinze JV, Nakayasu ES, Webb-Robertson BM, Inshaw JRJ, Marchetti P, Piemonti L, Esteller M, Todd JA, Metz TO, Eizirik DL, Pasquali L.

Nat Genet. 2019 Nov;51(11):1588-1595. doi: 10.1038/s41588-019-0524-6. Epub 2019 Nov 1.

PMID:
31676868
25.

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.

Krasniqi E, Barchiesi G, Pizzuti L, Mazzotta M, Venuti A, Maugeri-Saccà M, Sanguineti G, Massimiani G, Sergi D, Carpano S, Marchetti P, Tomao S, Gamucci T, De Maria R, Tomao F, Natoli C, Tinari N, Ciliberto G, Barba M, Vici P.

J Hematol Oncol. 2019 Oct 29;12(1):111. doi: 10.1186/s13045-019-0798-2. Review.

26.

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.

Capoluongo E, La Verde N, Barberis M, Bella MA, Buttitta F, Carrera P, Colombo N, Cortesi L, Gion M, Guarneri V, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A, Gori S.

Diagnostics (Basel). 2019 Oct 9;9(4). pii: E146. doi: 10.3390/diagnostics9040146.

27.

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.

Sipeky C, Llerena A, Manolopoulos VG, Pearson E, Mlakar V, Gozzo L, Simmaco M, Marchetti P, Re MD, Stankovic S, Meyer U, Cascorbi I, Ingelman-Sundberg M, Suarez-Kurtz G, Marc J, Katsila T, Paulmichl M, Nofziger C, Ansari M, Drago F, van Schaik RH.

Pharmacogenomics. 2019 Oct;20(15):1063-1069. doi: 10.2217/pgs-2019-0095.

PMID:
31588876
28.

Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.

Ciccarone M, Hohaus S, Pulsoni A, Cavaceppi P, Franzò S, Fabbri R, Cudillo L, Battistini R, Di Rocco A, Annibali O, Cox MC, Provenzano I, Abruzzese E, Renzi D, Tesei C, Anticoli Borza P, Cuccaro A, Andriani A, D'Elia GM, Facchiano A, Marchetti P, Cantonetti M.

Eur J Cancer Care (Engl). 2020 Jan;29(1):e13174. doi: 10.1111/ecc.13174. Epub 2019 Sep 30.

PMID:
31571303
29.

Response to: Comment on "Impact of tumor site on the prognosis of small bowel adenocarcinoma".

Falcone R, Strigari L, Farina L, Marchetti P.

Tumori. 2019 Dec;105(6):532. doi: 10.1177/0300891619878898. Epub 2019 Sep 30. No abstract available.

PMID:
31570060
30.

Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment.

Ascierto PA, Borgognoni L, Botti G, Guida M, Marchetti P, Mocellin S, Muto P, Palmieri G, Patuzzo R, Quaglino P, Stanganelli I, Caracò C.

J Transl Med. 2019 Sep 18;17(1):315. doi: 10.1186/s12967-019-2067-0.

31.

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.

Cazzaniga ME, Pinotti G, Montagna E, Amoroso D, Berardi R, Butera A, Cagossi K, Cavanna L, Ciccarese M, Cinieri S, Cretella E, De Conciliis E, Febbraro A, Ferraù F, Ferzi A, Fiorentini G, Fontana A, Gambaro AR, Garrone O, Gebbia V, Generali D, Gianni L, Giovanardi F, Grassadonia A, Leonardi V, Marchetti P, Melegari E, Musolino A, Nicolini M, Putzu C, Riccardi F, Santini D, Saracchini S, Sarobba MG, Schintu MG, Scognamiglio G, Spadaro P, Taverniti C, Toniolo D, Tralongo P, Turletti A, Valenza R, Valerio MR, Vici P, Clivio L, Torri V; VICTOR Study Group.

Breast. 2019 Dec;48:7-16. doi: 10.1016/j.breast.2019.07.006. Epub 2019 Aug 22.

PMID:
31470257
32.

Different Knee and Ankle Positions Affect Force and Muscle Activation During Prone Leg Curl in Trained Subjects.

Marchetti PH, Magalhaes RA, Gomes WA, da Silva JJ, Stecyk SD, Whiting WC.

J Strength Cond Res. 2019 Aug 29. doi: 10.1519/JSC.0000000000003333. [Epub ahead of print]

PMID:
31469769
33.

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker.

Ursini CL, Omodeo Salè E, Fresegna AM, Ciervo A, Jemos C, Maiello R, Buresti G, Colosio C, Rubino FM, Mandić-Rajčević S, Chiarella P, Carbonari D, Delrio P, Maiolino P, Marchetti P, Boccia R, Iavicoli S, Cavallo D.

Toxicol Lett. 2019 Nov;316:20-26. doi: 10.1016/j.toxlet.2019.08.022. Epub 2019 Aug 26.

PMID:
31465813
34.

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Facchini G, Rossetti S, Berretta M, Cavaliere C, Scagliarini S, Vitale MG, Ciccarese C, Di Lorenzo G, Palesandro E, Conteduca V, Basso U, Naglieri E, Farnesi A, Aieta M, Borsellino N, La Torre L, Iovane G, Bonomi L, Gasparro D, Ricevuto E, De Tursi M, De Vivo R, Lo Re G, Grillone F, Marchetti P, De Vita F, Scavelli C, Sini C, Pisconti S, Crispo A, Gebbia V, Maestri A, Galli L, De Giorgi U, Iacovelli R, Buonerba C, Cartenì G, D'Aniello C.

J Transl Med. 2019 Aug 29;17(1):296. doi: 10.1186/s12967-019-2047-4.

35.

Different volumes and intensities of static stretching affect the range of motion and muscle force output in well-trained subjects.

Marchetti PH, Miyatake MMS, Magalhaes RA, Gomes WA, Da Silva JJ, Brigatto FA, Zanini TCC, Behm DG.

Sports Biomech. 2019 Aug 29:1-10. doi: 10.1080/14763141.2019.1648540. [Epub ahead of print]

PMID:
31464179
36.

Sometimes, the Least Demanding Solution Is the Most Suitable: A Careful Survey of NMR Spectra of a Phosphonium Salt Accounted for Its "Unusual Wittig Reaction".

Fantinati A, Marchetti P, Trapella C, Zanirato V.

ACS Omega. 2018 Jul 19;3(7):8091-8096. doi: 10.1021/acsomega.8b01228. eCollection 2018 Jul 31.

37.

Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents.

Rossi A, Roberto M, Panebianco M, Botticelli A, Mazzuca F, Marchetti P.

Eur J Pharmacol. 2019 Nov 5;862:172621. doi: 10.1016/j.ejphar.2019.172621. Epub 2019 Aug 22. Review.

38.

Benefits of cryopreserved human amniotic membranes in association with conventional treatments in the management of full-thickness burns.

Hatzfeld AS, Pasquesoone L, Germain N, Danzé PM, Drucbert AS, Tardivel M, Bongiovanni A, Duquennoy-Martinot V, Guerreschi P, Marchetti P.

Int Wound J. 2019 Dec;16(6):1354-1364. doi: 10.1111/iwj.13198. Epub 2019 Aug 19.

PMID:
31429202
39.

New paradigm for stage III melanoma: from surgery to adjuvant treatment.

Ascierto PA, Borgognoni L, Botti G, Guida M, Marchetti P, Mocellin S, Muto P, Palmieri G, Patuzzo R, Quaglino P, Stanganelli I, Caracò C.

J Transl Med. 2019 Aug 14;17(1):266. doi: 10.1186/s12967-019-2012-2. Review. Erratum in: J Transl Med. 2019 Sep 18;17(1):315.

40.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Cortellini A, Leonetti A, Catino A, Pizzutillo P, Ricciuti B, De Giglio A, Chiari R, Bordi P, Santini D, Giusti R, De Tursi M, Brocco D, Zoratto F, Rastelli F, Citarella F, Russano M, Filetti M, Marchetti P, Berardi R, Torniai M, Cortinovis D, Sala E, Maggioni C, Follador A, Macerelli M, Nigro O, Tuzi A, Iacono D, Migliorino MR, Banna G, Porzio G, Cannita K, Ferrara MG, Bria E, Galetta D, Ficorella C, Tiseo M.

Clin Transl Oncol. 2019 Aug 7. doi: 10.1007/s12094-019-02193-w. [Epub ahead of print]

PMID:
31392645
41.

The expression of genes in top obesity-associated loci is enriched in insula and substantia nigra brain regions involved in addiction and reward.

Ndiaye FK, Huyvaert M, Ortalli A, Canouil M, Lecoeur C, Verbanck M, Lobbens S, Khamis A, Marselli L, Marchetti P, Kerr-Conte J, Pattou F, Marre M, Roussel R, Balkau B, Froguel P, Bonnefond A.

Int J Obes (Lond). 2019 Aug 6. doi: 10.1038/s41366-019-0428-7. [Epub ahead of print]

PMID:
31388097
42.

Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study.

Mazzuca F, Roberto M, Arrivi G, Sarfati E, Schipilliti FM, Crimini E, Botticelli A, Di Girolamo M, Muscaritoli M, Marchetti P.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419866920. doi: 10.1177/1534735419866920.

43.

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases.

Cortinovis D, Chiari R, Catino A, Grossi F, DE Marinis F, Sperandi F, Piantedosi F, Vitali M, Parra HJS, Migliorino MR, Tondini C, Tassinari D, Frassoldati A, Verderame F, Pazzola A, Cognetti F, Palmiotti G, Marchetti P, Santoro A, Giannarelli D, Colonese F, Delmonte A.

Anticancer Res. 2019 Aug;39(8):4265-4271. doi: 10.21873/anticanres.13590.

PMID:
31366516
44.

First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study.

Germain N, Dessein AF, Vienne JC, Dobbelaere D, Mention K, Joncquel M, Dekiouk S, Laine W, Kluza J, Marchetti P.

Int J Med Sci. 2019 Jun 7;16(7):931-938. doi: 10.7150/ijms.32413. eCollection 2019.

45.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583. [Epub ahead of print]

PMID:
31330065
46.

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.

Parisi A, Cortellini A, Roberto M, Venditti O, Santini D, Dell'Aquila E, Stellato M, Marchetti P, Occhipinti MA, Zoratto F, Mazzuca F, Tinari N, De Tursi M, Iezzi L, Natoli C, Ratti M, Pizzo C, Ghidini M, Porzio G, Ficorella C, Cannita K.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2365-2373. doi: 10.1007/s00432-019-02971-7. Epub 2019 Jul 6.

PMID:
31280347
47.

The microRNAs miR-211-5p and miR-204-5p modulate ER stress in human beta cells.

Grieco FA, Schiavo AA, Brozzi F, Juan-Mateu J, Bugliani M, Marchetti P, Eizirik D.

J Mol Endocrinol. 2019 Jul 1. pii: JME-19-0066.R1. doi: 10.1530/JME-19-0066. [Epub ahead of print]

PMID:
31277072
48.

Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study.

Grosso A, Pesce G, Marcon A, Piloni D, Albicini F, Gini E, Marchetti P, Battaglia S, Ferrari M, Fois A, Piccioni P, Antonicelli L, Verlato G, Corsico AG.

Respir Med. 2019 Aug;155:6-12. doi: 10.1016/j.rmed.2019.06.025. Epub 2019 Jun 30.

PMID:
31272012
49.

mTORC1 to AMPK switching underlies β-cell metabolic plasticity during maturation and diabetes.

Jaafar R, Tran S, Shah AN, Sun G, Valdearcos M, Marchetti P, Masini M, Swisa A, Giacometti S, Bernal-Mizrachi E, Matveyenko A, Hebrok M, Dor Y, Rutter GA, Koliwad SK, Bhushan A.

J Clin Invest. 2019 Jul 2;130:4124-4137. doi: 10.1172/JCI127021.

50.

Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer.

Annunziata MC, De Stefano A, Fabbrocini G, Leo S, Marchetti P, Romano MC, Romano I.

Clin Drug Investig. 2019 Sep;39(9):825-834. doi: 10.1007/s40261-019-00811-7. Review.

PMID:
31264159

Supplemental Content

Loading ...
Support Center